Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
The Lancet. Digital Health
|
April 4, 2025
Generating evidence to support the role of AI in diabetic eye screening: considerations from the UK National Screening Committee
Trystan Macdonald, Zhivko Zhelev, Xiaoxuan Liu, et al.
Health Technology Assessment (Winchester, England)
|
June 1, 2021
Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study
Noemi Lois, Jonathan Cook, Ariel Wang, et al.
Ophthalmology
|
July 30, 2021
Diagnostic Accuracy of Monitoring Tests of Fellow Eyes in Patients with Unilateral Neovascular Age-Related Macular Degeneration: Early Detection of Neovascular Age-Related Macular Degeneration Study
Sobha Sivaprasad, Katie Banister, Augusto Azuro-Blanco, et al.
BMJ Open
|
July 1, 2019
Effectiveness of Multimodal imaging for the Evaluation of Retinal oedema And new vesseLs in Diabetic retinopathy (EMERALD)
Noemi Lois, Jonathan Cook, Stephen Aldington, et al.
Ophthalmology
|
November 1, 2020
Evaluation of a New Model of Care for People with Complications of Diabetic Retinopathy: The EMERALD Study
Noemi Lois, Jonathan A Cook, Ariel Wang, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
November 10, 2025
What are the perceptions and concerns of people living with diabetes and National Health Service staff around the potential implementation of AI-assisted screening for diabetic eye disease?
Kathryn Willis, Royce Shakespeare, Lakshmi Chandrasekaran, et al.
Journal of Clinical Medicine
|
April 30, 2020
The Usefulness of Serum Biomarkers in the Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial
Cristina Hernández, Massimo Porta, Francesco Bandello, et al.
Diabetes
|
November 4, 2018
Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial
Rafael Simó, Cristina Hernández, Massimo Porta, et al.
BMC Public Health
|
March 14, 2024
Extending the diabetic retinopathy screening intervals in Singapore: methodology and preliminary findings of a cohort study
Amudha Aravindhan, Eva K Fenwick, Aurora Wing Dan Chan, et al.
Diabetes
|
July 1, 2017
Functional and Structural Findings of Neurodegeneration in Early Stages of Diabetic Retinopathy: Cross-sectional Analyses of Baseline Data of the EUROCONDOR Project
Ana Rita Santos, Luísa Ribeiro, Francesco Bandello, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
The Lancet. Digital Health
|
April 4, 2025
Generating evidence to support the role of AI in diabetic eye screening: considerations from the UK National Screening Committee
Trystan Macdonald, Zhivko Zhelev, Xiaoxuan Liu, et al.
Health Technology Assessment (Winchester, England)
|
June 1, 2021
Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study
Noemi Lois, Jonathan Cook, Ariel Wang, et al.
Ophthalmology
|
July 30, 2021
Diagnostic Accuracy of Monitoring Tests of Fellow Eyes in Patients with Unilateral Neovascular Age-Related Macular Degeneration: Early Detection of Neovascular Age-Related Macular Degeneration Study
Sobha Sivaprasad, Katie Banister, Augusto Azuro-Blanco, et al.
BMJ Open
|
July 1, 2019
Effectiveness of Multimodal imaging for the Evaluation of Retinal oedema And new vesseLs in Diabetic retinopathy (EMERALD)
Noemi Lois, Jonathan Cook, Stephen Aldington, et al.
Ophthalmology
|
November 1, 2020
Evaluation of a New Model of Care for People with Complications of Diabetic Retinopathy: The EMERALD Study
Noemi Lois, Jonathan A Cook, Ariel Wang, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
November 10, 2025
What are the perceptions and concerns of people living with diabetes and National Health Service staff around the potential implementation of AI-assisted screening for diabetic eye disease?
Kathryn Willis, Royce Shakespeare, Lakshmi Chandrasekaran, et al.
Journal of Clinical Medicine
|
April 30, 2020
The Usefulness of Serum Biomarkers in the Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial
Cristina Hernández, Massimo Porta, Francesco Bandello, et al.
Diabetes
|
November 4, 2018
Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial
Rafael Simó, Cristina Hernández, Massimo Porta, et al.
BMC Public Health
|
March 14, 2024
Extending the diabetic retinopathy screening intervals in Singapore: methodology and preliminary findings of a cohort study
Amudha Aravindhan, Eva K Fenwick, Aurora Wing Dan Chan, et al.
Diabetes
|
July 1, 2017
Functional and Structural Findings of Neurodegeneration in Early Stages of Diabetic Retinopathy: Cross-sectional Analyses of Baseline Data of the EUROCONDOR Project
Ana Rita Santos, Luísa Ribeiro, Francesco Bandello, et al.
Page
of 3